Treatment of 11 patients with chronic myelogenous leukemia with interferon-alpha-2C and low-dose cytosine arabinoside.

J Thaler; T Fluckinger; H Huber; A Lang; C Abbrederis; H Seewann; Heinz Sill; C Baldinger; C Duba; C Huber

doi:10.1016/0145-2126(93)90079-Z

Treatment of 11 patients with chronic myelogenous leukemia with interferon-alpha-2C and low-dose cytosine arabinoside.

J Thaler
, T Fluckinger
, H Huber
, A Lang
, C Abbrederis
, H Seewann
, Heinz Sill
, C Baldinger
, C Duba
, C Huber

Department of Internal Medicine

Research output: Contribution to journal › Communication

13 Citations (Web of Science)

Original language	English
Journal	Leukemia Research
DOIs	https://doi.org/10.1016/0145-2126(93)90079-Z
Publication status	Published - 1993

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

106 Biology
302 Clinical Medicine

DOI

10.1016/0145-2126(93)90079-Z

Links

Cite this

@article{cfeefe6561434fee8797b593a57e705c,

title = "Treatment of 11 patients with chronic myelogenous leukemia with interferon-alpha-2C and low-dose cytosine arabinoside.",

author = "J Thaler and T Fluckinger and H Huber and A Lang and C Abbrederis and H Seewann and Heinz Sill and C Baldinger and C Duba and C Huber",

year = "1993",

doi = "10.1016/0145-2126(93)90079-Z",

language = "English",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Treatment of 11 patients with chronic myelogenous leukemia with interferon-alpha-2C and low-dose cytosine arabinoside.

AU - Thaler, J

AU - Fluckinger, T

AU - Huber, H

AU - Lang, A

AU - Abbrederis, C

AU - Seewann, H

AU - Sill, Heinz

AU - Baldinger, C

AU - Duba, C

AU - Huber, C

PY - 1993

Y1 - 1993

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:A1993LU78800014

UR - https://pubmed.ncbi.nlm.nih.gov/8355515

U2 - 10.1016/0145-2126(93)90079-Z

DO - 10.1016/0145-2126(93)90079-Z

M3 - Communication

C2 - 8355515

SN - 0145-2126

JO - Leukemia Research

JF - Leukemia Research

ER -